share_log

Vanda Pharmaceuticals Sees FY22 Sales $240M-$280M Vs. $265.1M Est.

Benzinga Real-time News ·  Aug 3, 2022 16:30
Vanda Pharmaceuticals Sees FY22 Sales $240M-$280M Vs. $265.1M Est.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment